Hyperliquid vs Mira — how do they compare? Hyperliquid trades at Rp992,572 (market cap Rp251,81T, Rp3,42T 24h volume), while Mira trades at Rp701.98 (market cap Rp226,43M, Rp101,47M 24h volume). The key difference: Hyperliquid is far larger — about 1112087.6× Mira's market cap, and Hyperliquid's circulating supply is 252,6M / 952,6M HYPE (27%) versus 321,5M / 1B MIRA (33%) for Mira. Which is the better fit depends on your goals — on Pluang, investors hold Hyperliquid for 36 Days and Mira for 22 Days on average.
| HYPE | MIRA | |
|---|---|---|
Market Cap | Rp251,81T | Rp226,43M |
Volume (24h) | Rp3,42T | Rp101,47M |
Circulating Supply | 252,6M / 952,6M HYPE (27%) | 321,5M / 1B MIRA (33%) |
Typical Hold Time | 36 Days | 22 Days |
Signals from Pluang's Aura AI — not financial advice
Hyperliquid (HYPE) is trading at Rp1,020,245 with a market cap of Rp257.99 trillion, showing bullish technical signals from moving averages and a neutral stance from oscillators. The current price sits near the pivot point of Rp1,024,207, with support at Rp1,003,796 and resistance at Rp1,047,584. Recent on-chain activity indicates a hold time of 36 days, suggesting moderate holder confidence.
Overall outlook is cautiously optimistic due to technical strength, but key risks include high volatility and limited fundamental updates. Opportunities lie in potential breakout above resistance, while major risks involve regulatory uncertainty and liquidity constraints typical of crypto assets.
MIRA token trades at Rp724 with bearish technical signals as moving averages indicate strong selling pressure. The token shows neutral oscillators but faces resistance at Rp726-758 levels. With 33% circulating supply and 22-day average hold time, market participation remains limited. Recent ecosystem developments show progress in pharmaceutical research applications, though direct token utility updates are scarce.
Overall outlook remains cautious due to technical bearishness and limited trading volume. Key opportunity lies in potential protocol adoption from pharmaceutical research partnerships. Major risks include low liquidity, high volatility, and regulatory uncertainty surrounding crypto-pharma intersections. Investors should monitor exchange listings and token utility expansion.
What Pluang investors did over the last 30 days
Latest headlines on both assets
Hyperliquid is an advanced blockchain platform designed to improve the efficiency and performance of decentralized finance (DeFi) applications. It is built on a custom Layer 1 blockchain that has been specifically engineered for optimal scalability and speed. A key feature of its design is HyperBFT, a proprietary consensus mechanism that provides rapid transaction finality while ensuring high security standards.
Read more on HYPE →Mira is a decentralized verification network that enables autonomous AI by eliminating human oversight. Using consensus-based verification across multiple AI models, Mira delivers mathematically verifiable and trustless results in real time. This ensures accuracy and reliability for critical fields like healthcare, finance, and law—transforming AI from a supervised tool into truly independent intelligence.
Read more on MIRA →